Ryan Downie

Key Points FedEx is near all-time highs for several important financial metrics. The company has maintained profit margins despite lower delivery volumes. FedEx stock is reasonably priced relative to its earnings and potential dividend growth. Motley Fool Issues Rare “All In” Buy Alert

Key Points BigBear's market cap needs to triple to surpass $1 billion. The company's recent financial results paint an uncertain picture. The stock's reasonable valuation ratios likely need to increase if the company will be worth $1 billion by next year. 10 stocks we like better than BigBear.ai

Key Points Hubspot stock sank after a proposed acquisition of the company fell through. Its recent financial results have been positive, and little has changed about the company's operational outlook. The stock's expensive valuation contributed to volatility, and that might remain an issue for investors to consider. Motley Fool Issues Rare “All In” Buy Alert

Key Points Retirement plans should be tailored to personal goals and circumstances rather than average numbers for a broad population. You should concentrate on factors that you control, such as savings rate and investment allocation. To ensure that you meet your goals over the years, it's essential that you track your progress.

Shares of Eli Lilly (NYSE: LLY) fell 20% in July, according to data from S&P Global Market Intelligence . The pharmaceutical stock tumbled after

Key Points Datadog plunged with other tech stocks after a serious IT outage in July. Datadog's reported interest in acquiring GitLabs doesn't seem popular with the market right now. Reduced investor risk tolerance is pulling expensive growth stocks downward.

Key Points Amazon keeps adding to its dominant market share in a growth industry. Visa is a cash-flow powerhouse that's successfully maintaining its competitive position by embracing innovation. Home Depot leads a cyclical industry with bullish long-term demand drivers. Motley Fool Issues Rare “All In” Buy Alert

Key Points Eli Lilly's weight loss drugs are pushing the company's market cap toward $1 trillion. Johnson & Johnson is the global leader in drug sales, but its market cap is under $400 billion. It's not entering the obesity drug market, but it has a diverse product portfolio and an exceptionally strong pipeline.

It's hard to argue with results, and the Oracle of Omaha has an extensive track record of great investments.

Key Points D.R. Horton is the largest U.S. homebuilder, and the stock has been hitting all-time highs. The company increased its market share in an industry that outpaced the overall housing sector. The shares are still reasonable valued despite their slight premium to peers and historical levels. 10 stocks we like better than D.R. Horton